Protease-activated receptor-2 ligands reveal orthosteric and allosteric mechanisms of receptor inhibition
Kennedy et al. report the pharmacological and in vivo profiling of two small molecule PAR2 inhibitors and an agonist. They conclude that while the small molecule agonist and one of the inhibitors bind to the orthosteric PAR2 binding site, the other inhibitor is a negative allosteric modulator, highl...
Guardado en:
Autores principales: | Amanda J. Kennedy, Linda Sundström, Stefan Geschwindner, Eunice K. Y. Poon, Yuhong Jiang, Rongfeng Chen, Rob Cooke, Shawn Johnstone, Andrew Madin, Junxian Lim, Qingqi Liu, Rink-Jan Lohman, Anneli Nordqvist, Maria Fridén-Saxin, Wenzhen Yang, Dean G. Brown, David P. Fairlie, Niek Dekker |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e6a39fb1480d47f3b76e5e7e14d4b26c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Full-length human GLP-1 receptor structure without orthosteric ligands
por: Fan Wu, et al.
Publicado: (2020) -
Orthosteric- versus allosteric-dependent activation of the GABAA receptor requires numerically distinct subunit level rearrangements
por: Jahanshah Amin, et al.
Publicado: (2017) -
Structure-guided design of pure orthosteric inhibitors of αIIbβ3 that prevent thrombosis but preserve hemostasis
por: Brian D. Adair, et al.
Publicado: (2020) -
Molecular tuning of farnesoid X receptor partial agonism
por: Daniel Merk, et al.
Publicado: (2019) -
Orthosteric binding of ρ-Da1a, a natural peptide of snake venom interacting selectively with the α1A-adrenoceptor.
por: Arhamatoulaye Maïga, et al.
Publicado: (2013)